Internal Medicine, Geriatrics and Therapeutic Unit, AP-HM, Marseille, France and Coordination Unit for Geriatric Oncology (UCOG), PACA West, France; Aix-Marseille Univ, CNRS, EFS, ADES, Marseille, France.
Multidisciplinary Oncology and Therapeutic Innovations Department, AP-HM, Marseille, France; Aix-Marseille Univ, CNRS, INSERM, CRCM, Marseille, France.
J Geriatr Oncol. 2021 Apr;12(3):402-409. doi: 10.1016/j.jgo.2020.10.005. Epub 2020 Oct 21.
BACKGROUND: Lung cancer affects older and older old adults and is the leading cause of death by cancer. Comprehensive Geriatric Assessment (CGA) is recommended before and during cancer treatment to guide therapy management in this population. METHODS: This study was conducted between September 2015 and January 2019 at Marseille University Hospital (AP-HM). During this period, all consecutive outpatients 70 years or older referred for a CGA before initiation of lung cancer treatment were enrolled. The objective of this study was to compare lung and thoracic cancer management of octogenarians (≥80 years) and their geriatric profile versus patients aged 70 to 79 years (<80 years). FINDINGS: In our study, 228 patients were recruited. The median age was 78.7 ± 5 years. There were 94 octogenarians (41.2%), 36.2% of them were diagnosed with stage IV neoplasm and the most common treatment was chemotherapy (43.6%). The logistic regression analysis highlights that handgrip strength was the most commonly impaired domain (OR 2.3; 95% CI [1.3-4.3]) in octogenarians and that they are more likely than their younger counterparts to be treated by targeted therapy (OR 9.8; 95% CI [1.0-92.9]). Overall survival (OS) was similar in both age groups (log rank = 0,95). INTERPRETATION: In our study, octogenarians and patients <80 years had equivalent survival, across the different thoracic cancer treatments and tumor stages. Measure of muscle strength in CGA could be very useful in a clinical setting to help improve the management of older old patients treated for lung or thoracic cancer.
背景:肺癌影响着越来越多的老年人,是癌症死亡的主要原因。在癌症治疗之前和期间,建议进行全面老年评估(CGA),以指导该人群的治疗管理。
方法:这项研究于 2015 年 9 月至 2019 年 1 月在马赛大学医院(AP-HM)进行。在此期间,所有连续接受肺癌治疗前 CGA 评估的 70 岁或以上的门诊患者均被纳入研究。本研究的目的是比较 80 岁及以上的高龄患者(≥80 岁)与 70 至 79 岁患者(<80 岁)的肺癌和胸癌治疗方法及其老年综合评估结果。
发现:在我们的研究中,共纳入 228 例患者。中位年龄为 78.7 ± 5 岁。有 94 例患者(41.2%)为 80 岁以上高龄患者,其中 36.2%的患者被诊断为第四期肿瘤,最常见的治疗方法是化疗(43.6%)。逻辑回归分析显示,握力是高龄患者最常见的受损领域(OR 2.3;95%CI [1.3-4.3]),且他们比年轻患者更有可能接受靶向治疗(OR 9.8;95%CI [1.0-92.9])。两组的总生存期(OS)相似(对数秩检验= 0.95)。
结论:在我们的研究中,高龄患者和 80 岁以下患者在不同的胸部癌症治疗和肿瘤阶段的生存情况相似。CGA 中肌肉力量的测量在临床实践中可能非常有用,可以帮助改善老年患者肺癌或胸癌的治疗管理。
Ann Thorac Surg. 2008-2
Eur J Cardiothorac Surg. 2010-10-27
Eur Geriatr Med. 2021-10
Cancers (Basel). 2023-4-15
Curr Oncol Rep. 2022-11